Abstract
Smoking rates in people with depression and anxiety are twice as high as in the general population, even though people with depression and anxiety are motivated to stop smoking. Most healthcare professionals are aware that stopping smoking is one of the greatest changes that people can make to improve their health. However, smoking cessation can be a difficult topic to raise. Evidence suggests that smoking may cause some mental health problems, and that the tobacco withdrawal cycle partly contributes to worse mental health. By stopping smoking, a person's mental health may improve, and the size of this improvement might be equal to taking antidepressants. In this article we outline ways in which healthcare professionals can compassionately and respectfully raise the topic of smoking to encourage smoking cessation. We draw on evidence-based methods such as cognitive-behavioural therapy (CBT) and outline approaches that healthcare professionals can use to integrate these methods into routine care to help their patients stop smoking.
Original language | English |
---|---|
Pages (from-to) | 85-95 |
Number of pages | 11 |
Journal | British Journal of Psychiatry |
Volume | 27 |
Issue number | 2 |
Early online date | 10 Sept 2020 |
DOIs | |
Publication status | Published - 31 Mar 2021 |
Bibliographical note
Funding Information:G.M.J.T. is funded by a Cancer Research UK Population Researcher Postdoctoral Fellowship (C56067/A21330). A.L.B. is funded by a National Health and Medical Research Council (NHMRC) Senior Research Fellowship (G1601524). P.A. is a National Institute for Health Research (NIHR) senior investigator and is funded by NIHR Oxford's Biomedical Research Centre and Applied Research Centre. M.R.M. is a programme lead in the Medical Research Council Integrative Epidemiology Unit at the University of Bristol (MC_UU_00011/7).
Funding Information:
G.M.J.T. and M.R.M. have previously received funding from Pfizer, who manufacture smoking cessation products. P.A. led a trial funded by the NIHR and GlaxoSmithKline donated nicotine patches to the NHS in support of the trial. A.L.B. led trials funded by the NHMRC and GlaxoSmithKline donated nicotine replacement therapy in support of the trials.
Publisher Copyright:
Copyright © The Authors 2020.
Keywords
- Smoking cessation
- anxiety
- cognitive-behavioural therapy
- depression
- low mood
- practical guide
- stress
- theoretical review
ASJC Scopus subject areas
- Psychiatry and Mental health